Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about NASDAQ:TNXP

Recent news which mentions NASDAQ:TNXP

AI Security, “Netflix of China”, Healthcare Breakthroughs, Pure Play on $31 Billion Watch Market: iQIYI, TNXP, REGRF, AITX; Leaders Report Latest Advances

October 01, 2024

TNXP Stock Earnings: Tonix Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024

August 16, 2024

Tonix Pharmaceuticals Awarded potential 34 million dollar Contract with U.S. Department of Defence

July 19, 2024

Tonix Pharmaceuticals receives positive feedback from FDA on Tonmya™ for fibromyalgia management

July 18, 2024

Tonix Pharmaceuticals Nears Market Entry with Tonmya for Fibromyalgia Management

June 11, 2024

TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024

May 20, 2024

TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023

April 01, 2024

Tonix Pharmaceuticals drug TNX-102 SL gets FDA ok for US Department of Defense funded trial

February 28, 2024

Tonix Pharmaceuticals' Fibromyalgia Trial Shows Promising Results in Webinar Presentation

February 28, 2024

Tonix Pharmaceuticals announces key topline data from 2nd Phase 3 Clinical Trial of TNX-102 SL

January 02, 2024

Tonix Pharmaceuticals shared details of IND clearance for Phase 2 trial of TNX-2900

December 12, 2023

Tonix Pharmaceuticals' CEO reveals next-generation COVID vaccine technology chosen for key program

November 20, 2023

Tonix Pharmaceuticals finish Phase 3 trial of TNX-102 SL for management of Fibromyalgia

November 20, 2023

Tonix Pharmaceuticals releases positive results from Proof-Of-Concept Study on TNX-102 SL

September 19, 2023

Tonix Pharmaceuticals begins Phase 1 trial of TNX-1500 in healthy participants

August 28, 2023

Tonix Pharmaceuticals begins Phase 1 trial of TNX-1500 in healthy participants

August 21, 2023

Tonix Pharmaceuticals fibromyalgia study published in American College of Rheumatology

June 28, 2023

Tonix Pharmaceuticals shares breakthrough of TNX-601 ER study on patients with depression

May 31, 2023

Tonix Pharmaceuticals TNX-1500 monoclonal antibody published in American Journal of Transplantation

April 24, 2023

Tonix Pharmaceuticals announces acquisition of Healion Bio antiviral portfolio

February 24, 2023

Tonix Pharmaceuticals discusses exclusive license of potential monoclonal antibodies

February 02, 2023

Tonix CEO Calls for New Class of Covid-19 Pre-Exposure and Therapeutic Antibodies for High-Risk Populations

January 24, 2023

Why Is Tonix Pharmaceuticals (TNXP) Stock Up 40% Today?

December 12, 2022

Tonix Pharmaceuticals (TNXP) Stock Surges 15% on Patent News

August 01, 2022

Why Is Tonix Pharmaceuticals (TNXP) Stock Up 30% Today?

June 01, 2022

TNXP Stock Forecast: 12-month Price Target of $2.63 (Updated March 2022)

March 31, 2022

Tonix Pharmaceuticals Stock Belongs in the Biotech Dustbin

March 14, 2022

Why Is Tonix Pharmaceuticals (TNXP) Stock Up Today?

March 03, 2022

TNXP Stock Alert: The Migraine News Sending Tonix Pharmaceuticals Soaring

November 23, 2021

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.